Fluoroquinolones for the treatment of respiratory tract infections a review of clinical effectiveness, cost-effectiveness, and guidelines
This report aims to identify and synthesize the evidence describing the clinical effectiveness, cost-effectiveness, and evidence-based guidelines for the treatment of respiratory tract infections, including pneumonia and chronic obstructive pulmonary disease (COPD), using Fluoroquinolones
Main Authors: | , |
---|---|
Corporate Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Ottawa
CADTH
May 6, 2019, 2019
|
Edition: | Version 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | This report aims to identify and synthesize the evidence describing the clinical effectiveness, cost-effectiveness, and evidence-based guidelines for the treatment of respiratory tract infections, including pneumonia and chronic obstructive pulmonary disease (COPD), using Fluoroquinolones |
---|---|
Physical Description: | 1 PDF file (49 pages) illustrations |